[Federal Register Volume 62, Number 249 (Tuesday, December 30, 1997)]
[Notices]
[Pages 67901-67902]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33841]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Agency Information Collection Activities Extension of a Currently
Approved Collection; Comment Request
ACTION: Application for Procurement Quota for Controlled Substances.
-----------------------------------------------------------------------
The information collection is published to obtain comments from the
public and affected agencies. Comments are encouraged and will be
accepted until March 2, 1998.
We are requesting written comments and suggestions from the public
and affected agencies concerning the collection of information. Your
comments should address one or more of the following four points:
1. Evaluate whether the collection of information is necessary for
the proper performance of the functions of the agency, including
whether the information will have practical utility;
2. Evaluate the accuracy of the agencies estimate of the burden of
the collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Comments and/or suggestions regarding the item(s) contained in this
notice, especially regarding the estimated public burden and associated
response time should be directed to Mr. Frank Sapienza, 202-307-7183,
Chief, Drug and Chemical Evaluation Section, Office of Diversion
Control, Drug Enforcement Administration, Washington, DC 20537. If you
have additional comments, suggestions, or need a copy of the
information collection instrument with instructions, or additional
information, please contact Mr. Frank Sapienza.
Additionally, comments may also be submitted to the Department of
Justice (DOJ), Justice Management Division, Information Management and
Security Staff, Attention: Department Clearance Officer, Suite 850,
Washington Center, 1001 G Street, NW., Washington, DC 20530. Additional
comments may be submitted to DOJ via facsimile at 202-514-1590.
Overview of this information collection:
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Procurement Quota
for Controlled Substances. Agency form number: DEA Form 250; Applicable
component of the Department of Justice sponsoring the collection:
Office of Diversion Control, Drug Enforcement Administration,
Department of Justice.
3. Affected public who will be asked or required to respond, as
well as a brief abstract: Primary: Business or other for-profit. Other:
None.
Title 21, CFR, 1303.12 requires registered dosage form
manufacturers who wish to purchase controlled substances in Schedule II
to apply on DEA Form 250 for procurement quotas which limit purchase
quantities. The information collected is used for establishing quotas
and controlling procurement thereof.
4. An estimate of the total estimated number of respondents and the
amount of time estimated for an average respondent to respond: 531
respondents at 1 response per year at 1 hour per response.
[[Page 67902]]
5. An estimate of the total public burden (in hours) associated
with the collection: 531 annual burden hours.
Public comment on this proposed information collection is strongly
encouraged.
Dated: December 22, 1997.
Robert B. Briggs,
Department Clearance Officer, United States Department of Justice.
[FR Doc. 97-33841 Filed 12-29-97; 8:45 am]
BILLING CODE 4410-09-M
